Ernst Heinen Net Worth & Insider Trades
Ernst Heinen - Chief Development Officer, Aratana Therapeutics, Inc
What is Ernst Heinen's Net Worth?
The current estimated net worth of Aratana Therapeutics, Inc's Chief Development Officer, Ernst Heinen, is estimated to be about $869.65K . Ernst Heinen owns about 135,694 units of Aratana Therapeutics, Inc common stock. In the last 6 years at Aratana Therapeutics, Inc, Ernst Heinen has sold an estimated value of $869.65K worth.
What is Ernst Heinen's Past Insider Trading?
Ernst Heinen's largest sale order was 15,000 units , worth over $255.83K on July 17, 2015. In total, Ernst Heinen has made about 17 transactions over 6 years of their time at Aratana Therapeutics, Inc. Ernst Heinen usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 19,308 units , worth over $134.19K on November 9, 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ernst Heinen
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Ernst Heinen's' Mailing Address?
- Mailing address is C/o Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Leawood KS 66211 KS
Aratana Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Steven St. Peter, M.D. | 2018 | $528,390 | $654,948 | $649,006 | $247,000 | $11,000 | $2,090,344 |
| Steven St. Peter, M.D. | 2017 | $513,000 | $1,121,998 | $982,434 | $213,000 | $10,800 | $2,841,232 |
| Craig A. Tooman | 2018 | $360,000 | $191,751 | $189,953 | $110,900 | $11,000 | $863,604 |
| Craig A. Tooman | 2017 | $360,000 | $245,412 | $238,970 | $95,100 | $10,800 | $950,282 |
| Brent Standridge | 2018 | $315,000 | $191,751 | $189,953 | $92,100 | $11,000 | $799,804 |
| Brent Standridge | 2017 | $307,500 | $109,072 | $106,209 | $81,300 | $10,800 | $614,881 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1509190/000150919019000027/petx-20190419xdef14a.htm
What are Aratana Therapeutics, Inc's Past Insider Trades?
Aratana Therapeutics, Inc's most recent insider trade came on February 1, 2019 by John C Ayres who sold 3,125 units worth $13.09K . In the last 6 years, insiders at Aratana Therapeutics, Inc have sold an estimated value of $68.33M and bought an estimated value of $12.01M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are StSt, PRESIDENT AND CEO, Ernst Heinen, Chief Development Officer, and Julia A Stephanus, CHIEF COMMERCIAL OFFICER .
ARATANA THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||